Sagittarius Life Science Corp (3205.TWO)
TWD 31.75
(-1.85%)
TWD 31.75
(-1.85%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -69.36 Million | -52.89 Million | -29.18 Million | -62.24 Million | -104.5 Million |
| Net Income | -56.82 Million | -76.49 Million | -87.46 Million | -74 Million | -119.51 Million |
| Depreciation & Amortization | 15.03 Million | 20.91 Million | 24.17 Million | 26.03 Million | 26.42 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -26.07 Million | 862 Thousand | 34.24 Million | -15.11 Million | -18.72 Million |
| Other non-cash items | -2.81 Million | -2.45 Million | -871 Thousand | -2.53 Million | 7.31 Million |
| Investing Cash Flow | 22.44 Million | -1.13 Million | -104.82 Million | -42.11 Million | -10.84 Million |
| Investments in PPE | -2.01 Million | -1.09 Million | -8.43 Million | -11.2 Million | -14.68 Million |
| Acquisitions | 2 Million | -24.57 Million | - | - | 1 Million |
| Investment purchases | -5.61 Million | - | -97.1 Million | -30.59 Million | - |
| Sales/Maturities of investments | - | 23.01 Million | - | - | - |
| Other Investing Activities | 26.38 Million | 1.46 Million | 625 Thousand | -321 Thousand | 3.83 Million |
| Financing Cash Flow | -7.89 Million | -13.15 Million | -4.16 Million | -23.43 Million | -9.59 Million |
| Debt repayment | -8.39 Million | - | - | - | -11.05 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -8.74 Million | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | 501 Thousand | -715 Thousand | 11.93 Million | 2.17 Million | 1.45 Million |
| Accounts receivables | -3.22 Million | - | - | - | -2.61 Million |
| Accounts payables | -13.35 Million | - | - | - | -12.14 Million |
| Inventory | -3.6 Million | 632 Thousand | 4.31 Million | -9.56 Million | -6.42 Million |
| Other working capital | -19.24 Million | - | - | - | -9.69 Million |
| Cash at beginning of period | 189.48 Million | 255.65 Million | 394.23 Million | 522.52 Million | 648.12 Million |
| Cash at end of period | 133.89 Million | 189.48 Million | 255.65 Million | 394.23 Million | 522.52 Million |
| Capital Expenditure | -2.01 Million | -1.09 Million | -8.43 Million | -11.2 Million | -14.68 Million |
| Effect of forex changes on cash | -768 Thousand | 1 Million | -415 Thousand | -495 Thousand | -648 Thousand |
| Net cash flow / Change in cash | -55.58 Million | -66.17 Million | -138.57 Million | -128.28 Million | -125.59 Million |
| Free Cash Flow | -71.38 Million | -53.98 Million | -37.61 Million | -73.44 Million | -119.18 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -16.77 Million | -10.05 Million | -19.36 Million | -56.82 Million | -11.45 Million | -11.52 Million |
| Depreciation & Amortization | 3.87 Million | 3.74 Million | 3.73 Million | 15.03 Million | 3.74 Million | 3.76 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 10.9 Million | -8.86 Million | -3.76 Million | -26.07 Million | 14.25 Million | 9.89 Million |
| Other non-cash items | -772 Thousand | -395 Thousand | -934 Thousand | -2.81 Million | -577 Thousand | -962 Thousand |
| Investing Cash Flow | -10.69 Million | 26.1 Million | -14.01 Million | 22.44 Million | -16.8 Million | -183 Thousand |
| Investments in PPE | -590 Thousand | -904 Thousand | -89 Thousand | -2.01 Million | - | -190 Thousand |
| Acquisitions | - | - | 2 Million | 2 Million | - | - |
| Investment purchases | -9.63 Million | 26.52 Million | -1.25 Million | -5.61 Million | -32.86 Million | - |
| Sales/Maturities of investments | -9.63 Million | - | -14.37 Million | - | 14.37 Million | - |
| Other Investing Activities | -471 Thousand | 486 Thousand | -302 Thousand | 26.38 Million | -6000.00 | 7000.00 |
| Financing Cash Flow | -2.59 Million | -2.53 Million | -4.09 Million | -7.89 Million | -2.12 Million | 417 Thousand |
| Debt repayment | -2.58 Million | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -6000.00 | -3000.00 | -2 Million | 501 Thousand | 6000.00 | - |
| Accounts receivables | -1.04 Million | - | - | - | - | - |
| Accounts payables | -2.32 Million | - | - | - | - | - |
| Inventory | 7.89 Million | -7.62 Million | -5.08 Million | -3.6 Million | 3.13 Million | 223 Thousand |
| Other working capital | 6.37 Million | - | - | - | - | - |
| Cash at beginning of period | 140.21 Million | 133.89 Million | 172.45 Million | 189.48 Million | 185.26 Million | 184.02 Million |
| Cash at end of period | 125.23 Million | 140.21 Million | 133.89 Million | 133.89 Million | 172.45 Million | 185.26 Million |
| Capital Expenditure | -590 Thousand | -904 Thousand | -89 Thousand | -2.01 Million | - | -190 Thousand |
| Effect of forex changes on cash | 358 Thousand | 845 Thousand | -963 Thousand | -768 Thousand | 1.38 Million | -1.38 Million |
| Net cash flow / Change in cash | -14.97 Million | 6.31 Million | -38.56 Million | -55.58 Million | -12.81 Million | 1.24 Million |
| Free Cash Flow | -2.64 Million | -19 Million | -19.58 Million | -71.38 Million | 4.73 Million | 2.21 Million |
FWT
GIC
AVTX
CUTLF
3536
028670